Page 1 | Search Results | Blood | American Society of Hematology

1-18 of 18

Sort by

Sort Order Select

Journal Articles

Follicular lymphoma comprises germinal center–like and memory-like molecular subtypes with prognostic significance

Camille Laurent, Preeti Trisal, Bruno Tesson, Sahil Seth, Alicia Beyou, Sandrine Roulland, Bastien Lesne, Nathalie Van Acker, Juan-Pablo Cerapio, Loïc Chartier, Arnaud Guille, Matthew E. Stokes, C. Chris Huang, Sarah Huet, Anita K. Gandhi, Franck Morschhauser, Luc Xerri

Blood (2024) 144 (24): 2503–2516.

https://doi.org/10.1182/blood.2024024496

Published: 2024

Includes: Supplemental data

Journal Articles

Myeloid Neoplasia after CD19 Directed CAR-T Cells : Cumulative Incidence, Risk Factors and Outcome

Nicolas Gazeau, David Beauvais, Rémi Tilmont, Micha Srour, Emmanuelle Ferrant, Violaine Safar, Gandhi Damaj, Nicolas Gower, Nicolas Duployez, Sarah Huet, Herve Ghesquieres, Emmanuel Bachy, Franck Morschhauser, Ibrahim Yakoub-Agha, Mael Heiblig, Pierre Sesques

Blood (2024) 144 (Supplement 1): 2079.

https://doi.org/10.1182/blood-2024-208851

Published: 2024

Journal Articles

Correlation of Clonal Hematopoiesis in Vexas Syndrome with Immunophenotype Alterations in CD34+ HSPCs (Hematopoietic Stem Progenitors Cells): Multiparametric Flow Cytometry Heterogeneity in CD34+CD38- Stem Cells Fraction and Upregulation of CD90 Thy-1 By Unsupervised Strategy Using PCA, Tsnee and Flowsom

Adriana Plesa, Joris Gutrin, Christophe Roumier, Sandrine Hayette, Isabelle Tigaud, Sarah Huet, Delphine Manzoni, Florent Dumezy, Fiorenza Barraco, Herve Ghesquieres, Claude Preudhomme, Pierre Sujobert, Mael Heiblig

Blood (2022) 140 (Supplement 1): 4086–4087.

https://doi.org/10.1182/blood-2022-169959

Published: 2022

Journal Articles

Treatment dependence of prognostic gene expression signatures in de novo follicular lymphoma

Christopher R. Bolen, Federico Mattiello, Michael Herold, Wolfgang Hiddemann, Sarah Huet, Wolfram Klapper, Robert Marcus, Farheen Mir, Gilles Salles, Oliver Weigert, Tina Nielsen, Mikkel Z. Oestergaard, Jeffrey M. Venstrom

Blood (2021) 137 (19): 2704–2707.

https://doi.org/10.1182/blood.2020008119

Published: 2021

Includes: Supplemental data

Journal Articles

Neoantigens in Patients with De Novo Follicular Lymphoma: Results from the PRIMA Study

Carsten Henneges, Dexter X Jin, Jeffrey M Venstrom, Sally E Trabucco, PhD, Tina G Nielsen, Elicia M. Penuel, Sarah Huet, Gilles Salles, MD PhD, Joseph N Paulson

Blood (2020) 136 (Supplement 1): 25–26.

https://doi.org/10.1182/blood-2020-134795

Published: 2020

Journal Articles

High Dimensional Tissue-Based Spatial Analysis of the Tumor Microenvironment of Follicular Lymphoma Reveals Unique Immune Niches inside Malignant Follicles

Blood (2020) 136 (Supplement 1): 17–18.

https://doi.org/10.1182/blood-2020-134941

Published: 2020

Journal Articles

Real Time Pathological and Molecular Characterization of Aggressive B-Cell Lymphomas Based on a National Network. a Lysa Project

Christiane Copie Bergman, MDPhD, Elodie Bohers, PhD, Peggy Dartigues-Cuillères, MD, Pierre-Julien Viailly, Philippe Ruminy, PhD, Vinciane Marchand, Marie-Helene Delfau-Larue, Corinne Haioun, MDPhD, Cyrielle Robe, Elsa Poullot, MD, Steven Le Gouill, MD PhD, Yannick Le Bris, PharmD, Céline Bossard, MD, Anne Moreau, MD, Vincent Ribrag, MD, Valérie Camara-clayette, PhD, Cyril Quivoron, PhD, Gilles Salles, MDPhD, Sophie Cotteret, MD PhD, Pierre Sujobert, MD PhD, Alexandra Traverse-Glehen, MD PhD, Claire Mauduit, Pascaline Etancelin, Sarah Huet, Liana Veresezan, MD, Krimo Bouabdallah, MD, Marie Parrens, MD, Audrey Gros, PhD, Samuel Amintas, David Sibon, MD PhD, Ludovic Lhermitte, MD PhD, Thomas Steimle, Sophie Kaltenbach, Bettina Fabiani, MD, Camille Laurent, MD PhD, Barbara Burroni, Laurent Martin, MD PhD, Thierry Jo Molina, MDPhD, Lysa LYSARC study group, Fabrice Jardin, MD PhD

Blood (2020) 136 (Supplement 1): 22–23.

https://doi.org/10.1182/blood-2020-141953

Published: 2020

Journal Articles

Impact of DNMT3a Status on Post Induction NPM1 MRD Predictive Value on Survival in Elderly AML Patients Treated Intensively

Blood (2020) 136 (Supplement 1): 7–8.

https://doi.org/10.1182/blood-2020-141890

Published: 2020

Journal Articles

Implication of Inherited Genetic Variants Associated with Follicular Lymphoma Susceptibility in the Prognosis of Patients Treated By Immunochemotherapy in PRIMA Study

Herve Ghesquieres, MD PhD, Youenn Drouet, PhD, Sarah Huet, PharmD PhD, Guillaume Cartron, Marie-Helene Delfau, MD PhD, Fritz Offner, MD, Pauline Brice, Luc Xerri, MD PhD, Reda Bouabdallah, Gilles A. Salles, MD PhD

Blood (2019) 134 (Supplement_1): 2780.

https://doi.org/10.1182/blood-2019-130357

Published: 2019

Journal Articles

Desynchronization of the Germinal Center Dynamics and Remodeling of the Tumor Microenvironment Characterize KMT2 D -Driven Lymphomagenesis

Gabriel Brisou, MD, Manon Zala, Laurine Gil, Giulia Pagano, Agnès Bru, Inaki Cervera-Marzal, Delphine Potier, PhD, Sebastien Nin, Lionel Chasson, Caroline Laprie, DVM, Sarah Huet, PharmD PhD, Gilles Salles, MD PhD, Pierre Milpied, PhD, Bertrand Nadel, PhD, Sandrine Roulland, PharmD PhD

Blood (2018) 132 (Supplement 1): 670.

https://doi.org/10.1182/blood-2018-99-116617

Published: 2018

Journal Articles

Validation of the prognostic value of the knowledge bank approach to determine AML prognosis in real life

Sarah Huet, Etienne Paubelle, Camille Lours, Beatrice Grange, Lucien Courtois, Kaddour Chabane, Carole Charlot, Isabelle Mosnier, Thomas Simonet, Sandrine Hayette, Isabelle Tigaud, Xavier Thomas, Gilles Salles, Fabien Subtil, Pierre Sujobert

Blood (2018) 132 (8): 865–867.

https://doi.org/10.1182/blood-2018-03-840348

Published: 2018

Includes: Supplemental data

Journal Articles

Measurement of PD-1 Expression on Lymphoma Cells By Flow Cytometry Is a Useful Tool in Diagnosing and Monitoring Minimal Residual Disease in Angioimmunoblastic T-Cell Lymphoma

Mariko Yabe, Neval Ozkaya, Qi Gao, Janine Pichardo, Sarah Huet, Alison J. Moskowitz, MD, Steven M. Horwitz, MD, Ahmet Dogan, MD PhD, Mikhail Roshal, MDPhD

Blood (2017) 130 (Supplement 1): 1516.

https://doi.org/10.1182/blood.V130.Suppl_1.1516.1516

Published: 2017

Journal Articles

Absence of driver mutations in persistent polyclonal B-cell lymphocytosis with binucleated lymphocytes

Bruno Tesson, Sarah Huet, Béatrice Grange, Laurent Jallades, Lucile Baseggio, Pascale Felman, Alexandra Traverse-Glehen, Jean-Pierre Magaud, Jean-Christophe Lega, Christine Bole-Feysot, Gilles Salles, Evelyne Callet-Bauchu, Pierre Sujobert

Blood (2017) 130 (10): 1267–1269.

https://doi.org/10.1182/blood-2017-03-776674

Published: 2017

Includes: Supplemental data

Journal Articles

Comprehensive analysis of a myeloperoxidase-negative acute promyelocytic leukemia

Maël Heiblig, Etienne Paubelle, Adriana Plesa, Marie-Oldine Geay, Delphine Manzoni, Sophie Gazzo, Isabelle Tigaud, Evelyne Callet-Bauchu, Sarah Huet, Gilles Salles, Xavier Thomas, Sandrine Hayette, Pierre Sujobert

Blood (2017) 129 (1): 128–131.

https://doi.org/10.1182/blood-2016-09-741355

Published: 2017

Journal Articles

Mutation Load and a Functional T Effector Signature May Distinguish Immunologically Distinct and Clinically Relevant Lymphoma Subsets

Chris Bolen, PhD, Ronald McCord, PhD, Garrett Frampton, PhD, Richard Bourgon, PhD, Elizabeth A. Punnoose, PhD, Edith Szafer-Glusman, PhD, Pierre Sujobert, MD PhD, Luc Xerri, MD PhD, Sarah Huet, PharmD, PhD, Gilles Salles, MD PhD, Jeffrey M Venstrom

Blood (2016) 128 (22): 913.

https://doi.org/10.1182/blood.V128.22.913.913

Published: 2016

Journal Articles

Quantitative Assessment of Circulating Clonal IG-VDJ Sequences in Plasma of Follicular Lymphoma at Diagnosis Is Highly Predictive of Progression Free Survival (PFS)

Clémentine Sarkozy, MD, Sarah Huet, PharmD, PhD, Victoria Carlton, Alain Delmer, MD PhD, Fabrice Jardin, Marie-Helene Delfau-Larue, MD PhD, Malek Faham, Gilles Salles, MD PhD

Blood (2015) 126 (23): 2675.

https://doi.org/10.1182/blood.V126.23.2675.2675

Published: 2015

Journal Articles

Very Long-Term Follow-up (> 80 months) of Imatinib (IM) First-Line for Chronic Phase (CP) CML Patients

Franck E. Nicolini, MD PhD, Marie Balsat, MD, Maud Lekieffre, MD, Vincent Alcazer, MD, Hélène Labussière-wallet, MD, Sarah Huet, PharmD, PhD, Sandrine Hayette, Stéphanie Dulucq, PharmD, PhD, Stéphane Morisset, Stat, Jeremy Ruby, CRA, Isabelle Tigaud, MD, Marie-Pierre Fort, CRA, Mael Heiblig, MD, Rémi Chapelon, CRA, Madeleine Etienne, CRA, Mohamad Sobh, PharmD, Francois-Xavier Mahon, MD PhD Professor, Mauricette Michallet, MD PhD, Gabriel Etienne, MD PhD

Blood (2015) 126 (23): 2774.

https://doi.org/10.1182/blood.V126.23.2774.2774

Published: 2015

Journal Articles

Comparison Of BCR-ABL1/ABL1 and BCR-ABL1/GUS Ratios At Different Clinical Decision Cut-Offs In Chronic Phase Chronic Myelogenous Leukemia Patients On Imatinib

Sarah Huet, Denis Souche, Jean-Pierre Magaud, Pascale Cony-Makhoul, MD, Yann Guillermin, MD, Mael Heiblig, MD, Mauricette Michallet, MD, PhD, Franck E. Nicolini, MD, PhD, Sandrine Hayette, PhD

Blood (2013) 122 (21): 2713.

https://doi.org/10.1182/blood.V122.21.2713.2713

Published: 2013

NARROW

Follicular lymphoma comprises germinal center–like and memory-like molecular subtypes with prognostic significance

Myeloid Neoplasia after CD19 Directed CAR-T Cells : Cumulative Incidence, Risk Factors and Outcome

Treatment dependence of prognostic gene expression signatures in de novo follicular lymphoma

Neoantigens in Patients with De Novo Follicular Lymphoma: Results from the PRIMA Study

High Dimensional Tissue-Based Spatial Analysis of the Tumor Microenvironment of Follicular Lymphoma Reveals Unique Immune Niches inside Malignant Follicles

Real Time Pathological and Molecular Characterization of Aggressive B-Cell Lymphomas Based on a National Network. a Lysa Project

Impact of DNMT3a Status on Post Induction NPM1 MRD Predictive Value on Survival in Elderly AML Patients Treated Intensively

Implication of Inherited Genetic Variants Associated with Follicular Lymphoma Susceptibility in the Prognosis of Patients Treated By Immunochemotherapy in PRIMA Study

Desynchronization of the Germinal Center Dynamics and Remodeling of the Tumor Microenvironment Characterize KMT2 D -Driven Lymphomagenesis

Validation of the prognostic value of the knowledge bank approach to determine AML prognosis in real life

Measurement of PD-1 Expression on Lymphoma Cells By Flow Cytometry Is a Useful Tool in Diagnosing and Monitoring Minimal Residual Disease in Angioimmunoblastic T-Cell Lymphoma

Absence of driver mutations in persistent polyclonal B-cell lymphocytosis with binucleated lymphocytes

Comprehensive analysis of a myeloperoxidase-negative acute promyelocytic leukemia

Mutation Load and a Functional T Effector Signature May Distinguish Immunologically Distinct and Clinically Relevant Lymphoma Subsets

Quantitative Assessment of Circulating Clonal IG-VDJ Sequences in Plasma of Follicular Lymphoma at Diagnosis Is Highly Predictive of Progression Free Survival (PFS)

Very Long-Term Follow-up (> 80 months) of Imatinib (IM) First-Line for Chronic Phase (CP) CML Patients

Comparison Of BCR-ABL1/ABL1 and BCR-ABL1/GUS Ratios At Different Clinical Decision Cut-Offs In Chronic Phase Chronic Myelogenous Leukemia Patients On Imatinib

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only